Augmented awareness regarding medical applications of bonding coupled with rise in disorders such as cardiovascular, orthopedic and other target diseases which can be treated only through surgical methods, aging population, rising cases of abdominal surgery are key factors contributing to high CAGR of Anti-Bonding Products
According to the current analysis of Reports and Data, the global anti-bonding products market was valued at USD 594.0 Million in 2020 and is expected to reach USD 1,033.1 Million by the year 2028, at a CAGR of 7.10%. Bondings are bands of sticky tissues that adhere to the surfaces of internal organs and tissues together, creating an obstruction in the area of its formation. Bondings can result into severe medical conditions such as small bowel obstruction, frequent pain, infertility and motion restriction. Surgical procedures such as laparoscopy, meticulous hemostasis, and inflammatory drugs such as non-steroidal anti-inflammatory, corticosteroids, and calcium channel blockers are also prescribed. However, anti-bonding products called bonding barriers are suggested as the most effective way of reducing bondings. The anti-bonding products are used to treat these bondings as they cannot be handled by any drug therapy. The increasing incidence of associated surgeries such as gynecology, cardiovascular, orthopedic, abdominal surgery, and other surgeries, leading to this process, post surgeries would me majorly driving the market for surgical anti-bonding products.
The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.
Key companies operating in the market and profiled in the report include:
Stryker corporation, Artherex, Johnson and Johnson (DePuy Synthes), Smith and Nephew, Zimmer Biomet, Nordson Medical, Lemke vision, GPC Medical, Karl Storz, Conmed
The Anti-Bonding Products market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.
Segments Covered in the report
Product Outlook (Revenue in Million USD; 2020–2028)
- Synthetic Bonding
- Polyethylene Glycol
- Hyaluronic Acid
- Regenerated Cellulose
- Natural Bonding Barriers
- Collagen Protein
- Fibrin
Application Outlook (Revenue in Million USD; 2020–2028)
- Cardiovascular surgery
- Orthopedic surgery
- Gynecological surgery
- General/ abdominal Surgery
- Neurological surgery
- Urological Surgery
- Other surgeries
Formulation Outlook (Revenue in Million USD; 2020–2028)
- Gels
- Films
- Liquid
Key Regions Analyzed in the Report include:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Furthermore, it consists information about individual segment of the Anti-Bonding Products market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.
Further key findings from the report suggest
- Pelvic surgery often causes unavoidable tissue injury and that can lead to the formation of post- surgical bonding owning to the rising demand for anti-bonding products. The polyethylene glycol segment is expected to grow with a CAGR of 7.6% during the forecast period owing to its high efficacy and better results.
- The synthetic anti-adhesive products are extensively used out of which hyaluronic acid and regenerated cellulose are used after polyethylene glycol
- The target diseases such as cancer, pelvic surgeries, and C-sections have significantly increased in number owing to the rising demand for anti-bonding products. According to the National Cancer Institute in 2020, the most common cancers are lung cancer, bronchus cancer, breast cancer, prostate cancer, rectum cancer, colon cancer, melanoma of the skin, non-Hodgkin lymphoma, endometrial cancer, bladder cancer, and renal pelvis cancer.
- Due to stringent regulations for approval of anti-bonding products, companies often face a lot of difficulties for approval to establish product’s clinical efficacy and safety.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2470
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
